Journal
Blood Advances
Publication Date
8-27-2024
Volume
8
Issue
16
First Page
4414
Last Page
4422
Document Type
Open Access Publication
DOI
10.1182/bloodadvances.2024012838
Rights and Permissions
Khurana A, Mwangi R, Nastoupil LJ, Reagan PM, Farooq U, Romancik JT, McDonnell TJ, Riska SM, Lossos LS, Kahl BS, Martin P, Witzig TE, Cerhan JR, Flowers CR, Nowakowski GS, Maurer MJ. Evaluating the impact of laboratory-based eligibility criteria by race/ethnicity in first-line clinical trials of DLBCL. Blood Adv. 2024 Aug 27;8(16):4414-4422. doi: 10.1182/bloodadvances.2024012838. © 2024 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Recommended Citation
Khurana, Arushi; Kahl, Brad S; and et al., "Evaluating the impact of laboratory-based eligibility criteria by race/ethnicity in first-line clinical trials of DLBCL." Blood Advances. 8, 16. 4414 - 4422. (2024).
https://digitalcommons.wustl.edu/oa_4/4149
Additional Links
Supplemental material is available for this article at publisher site.
